Literature DB >> 12070304

Regulation of seizure spreading by neuroserpin and tissue-type plasminogen activator is plasminogen-independent.

Manuel Yepes1, Maria Sandkvist, Timothy A Coleman, Elizabeth Moore, Jiang-Young Wu, David Mitola, Thomas H Bugge, Daniel A Lawrence.   

Abstract

Tissue-type plasminogen activator (tPA) is a highly specific serine proteinase expressed in the CNS during events that require neuronal plasticity. In this study we demonstrate that endogenous tPA mediates the progression of kainic acid-induced (KA-induced) seizures by promoting the synchronization of neuronal activity required for seizure spreading, and that, unlike KA-induced cell death, this activity is plasminogen-independent. Specifically, seizure induction by KA injection into the amygdala induces tPA activity and cell death in both hippocampi, and unilateral treatment of rats with neuroserpin, a natural inhibitor of tPA in the brain, enhances neuronal survival in both hippocampi. Inhibition of tPA within the hippocampus by neuroserpin treatment does not prevent seizure onset but instead markedly delays the progression of seizure activity in both rats and wild-type mice. In tPA-deficient mice, seizure progression is significantly delayed, and neuroserpin treatment does not further delay seizure spreading. In contrast, plasminogen-deficient mice show a pattern of seizure spreading and a response to neuroserpin that is similar to that of wild-type animals. These findings indicate that tPA acts on a substrate other than plasminogen and that the effects of neuroserpin on seizure progression and neuronal cell survival are mediated through the inhibition of tPA.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12070304      PMCID: PMC151009          DOI: 10.1172/JCI14308

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  Familial encephalopathy with neuroserpin inclusion bodies.

Authors:  R L Davis; P D Holohan; A E Shrimpton; A H Tatum; J Daucher; G H Collins; R Todd; C Bradshaw; P Kent; D Feiglin; A Rosenbaum; M S Yerby; C M Shaw; F Lacbawan; D A Lawrence
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

2.  Activity-dependent formation of perforated synapses in cultured hippocampal neurons.

Authors:  H Neuhoff; J Roeper; M Schweizer
Journal:  Eur J Neurosci       Date:  1999-12       Impact factor: 3.386

3.  Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice.

Authors:  Y F Wang; S E Tsirka; S Strickland; P E Stieg; S G Soriano; S A Lipton
Journal:  Nat Med       Date:  1998-02       Impact factor: 53.440

4.  Status epilepticus-induced neuronal damage in the rat amygdaloid complex: distribution, time-course and mechanisms.

Authors:  J Tuunanen; K Lukasiuk; T Halonen; A Pitkänen
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

5.  Biochemical characterization of a neuroserpin variant associated with hereditary dementia.

Authors:  M Yazaki; J J Liepnieks; J R Murrell; M Takao; B Guenther; P Piccardo; M R Farlow; B Ghetti; M D Benson
Journal:  Am J Pathol       Date:  2001-01       Impact factor: 4.307

6.  The axonally secreted serine proteinase inhibitor, neuroserpin, inhibits plasminogen activators and plasmin but not thrombin.

Authors:  T Osterwalder; P Cinelli; A Baici; A Pennella; S R Krueger; S P Schrimpf; M Meins; P Sonderegger
Journal:  J Biol Chem       Date:  1998-01-23       Impact factor: 5.157

7.  Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis.

Authors:  M Yepes; M Sandkvist; M K Wong; T A Coleman; E Smith; S L Cohan; D A Lawrence
Journal:  Blood       Date:  2000-07-15       Impact factor: 22.113

8.  Familial dementia caused by polymerization of mutant neuroserpin.

Authors:  R L Davis; A E Shrimpton; P D Holohan; C Bradshaw; D Feiglin; G H Collins; P Sonderegger; J Kinter; L M Becker; F Lacbawan; D Krasnewich; M Muenke; D A Lawrence; M S Yerby; C M Shaw; B Gooptu; P R Elliott; J T Finch; R W Carrell; D A Lomas
Journal:  Nature       Date:  1999-09-23       Impact factor: 49.962

9.  Role of plasminogen system components in focal cerebral ischemic infarction: a gene targeting and gene transfer study in mice.

Authors:  N Nagai; M De Mol; H R Lijnen; P Carmeliet; D Collen
Journal:  Circulation       Date:  1999-05-11       Impact factor: 29.690

10.  The tissue plasminogen activator (tPA)/plasmin extracellular proteolytic system regulates seizure-induced hippocampal mossy fiber outgrowth through a proteoglycan substrate.

Authors:  Y P Wu; C J Siao; W Lu; T C Sung; M A Frohman; P Milev; T H Bugge; J L Degen; J M Levine; R U Margolis; S E Tsirka
Journal:  J Cell Biol       Date:  2000-03-20       Impact factor: 10.539

View more
  47 in total

Review 1.  Tissue plasminogen activator and seizures: a clot-buster's secret life.

Authors:  Robert Pawlak; Sidney Strickland
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

Review 2.  The contribution of L-arginine to the neurotoxicity of recombinant tissue plasminogen activator following cerebral ischemia: a review of rtPA neurotoxicity.

Authors:  George W J Harston; Brad A Sutherland; James Kennedy; Alastair M Buchan
Journal:  J Cereb Blood Flow Metab       Date:  2010-08-25       Impact factor: 6.200

Review 3.  Contribution of extracellular proteolysis and microglia to intracerebral hemorrhage.

Authors:  Jian Wang; Stella E Tsirka
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

4.  Tissue plasminogen activator mediates amyloid-induced neurotoxicity via Erk1/2 activation.

Authors:  Manel G Medina; Maria Dolores Ledesma; Jorge E Domínguez; Miguel Medina; Delia Zafra; Francesc Alameda; Carlos G Dotti; Pilar Navarro
Journal:  EMBO J       Date:  2005-04-21       Impact factor: 11.598

5.  Tissue plasminogen activator, neuroserpin, and seizures.

Authors:  Annamaria Vezzani
Journal:  Epilepsy Curr       Date:  2005 Jul-Aug       Impact factor: 7.500

6.  Tissue-type plasminogen activator requires a co-receptor to enhance NMDA receptor function.

Authors:  Andre L Samson; Simon T Nevin; David Croucher; Be'eri Niego; Philip B Daniel; Thomas W Weiss; Eliza Moreno; Denis Monard; Daniel A Lawrence; Robert L Medcalf
Journal:  J Neurochem       Date:  2008-09-15       Impact factor: 5.372

7.  Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke.

Authors:  Enming J Su; Linda Fredriksson; Melissa Geyer; Erika Folestad; Jacqueline Cale; Johanna Andrae; Yamei Gao; Kristian Pietras; Kris Mann; Manuel Yepes; Dudley K Strickland; Christer Betsholtz; Ulf Eriksson; Daniel A Lawrence
Journal:  Nat Med       Date:  2008-06-22       Impact factor: 53.440

8.  Tissue-type plasminogen activator is a neuroprotectant in the mouse hippocampus.

Authors:  Ramiro Echeverry; Jialing Wu; Woldeab B Haile; Johanna Guzman; Manuel Yepes
Journal:  J Clin Invest       Date:  2010-05-03       Impact factor: 14.808

Review 9.  Pharmacological targeting of the PDGF-CC signaling pathway for blood-brain barrier restoration in neurological disorders.

Authors:  Sebastian A Lewandowski; Linda Fredriksson; Daniel A Lawrence; Ulf Eriksson
Journal:  Pharmacol Ther       Date:  2016-08-12       Impact factor: 12.310

10.  pH-dependent stability of neuroserpin is mediated by histidines 119 and 138; implications for the control of beta-sheet A and polymerization.

Authors:  Didier Belorgey; Peter Hägglöf; Maki Onda; David A Lomas
Journal:  Protein Sci       Date:  2010-02       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.